$WT

WisdomTree Announces Second Quarter 2026 Results

WisdomTree, Inc. (WT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 WisdomTree Announces Second Quarter 2026 Results Record AUM of $162.9 Billion Diluted Earnings Per Share of $0.28; Adjusted Earnings Per Share of $0.31 13% Annualized Organic Flow Growth Rate Operating Margin Expanded by 780 bps Year over Year; or 900 bps, on an Adju

Original reporting
Published Jul 31, 2026, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 31, 2026, 12:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$WT
Bullish
high confidence
Mentioned
$WT
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$WTBullishMed
01

Why it matters

Traders can update models for fee economics (average advisory fee and revenue yield), margin trajectory (operating margin expansion), and balance-sheet/capital return (convertible note retirement and share repurchase).

02

Market read

Record AUM and positive net inflows alongside operating margin expansion are the core drivers for near-term repricing, with acquisition and launch-related expense dynamics as key watch items.

03

What to watch

Net inflows were partly offset by outflows in leveraged and inverse products, so the quality and durability of flows may be uneven across strategy types.

Relevance 7/10Novelty 7/10Timing: filed pre-market today, Q2 results and capital actions disclosed

Background

This is WisdomTree’s SEC 8-K (Item 2.02) with Q2 2026 operating and financial highlights, including AUM, flows, margins, and capital actions.

Company-level read

Ticker impact

$WTBullishHigh confidence
Context

WisdomTree reported Q2 2026 results with record AUM of $162.9B, EPS $0.28 diluted ($0.31 adjusted), and $3.1B net inflows.

Expected impact

Likely positive bias for the stock on earnings-day positioning, with follow-through dependent on whether inflows and margin expansion persist.

Evidence & confidence

The filing discloses multiple decision-relevant datapoints: record AUM, net inflows by product mix, operating margin expansion (GAAP and adjusted), and explicit capital return actions (note retirement and $25.9M repurchase).

Market effects

Supports the broader ETF and liquid alternatives complex narrative that diversified asset managers can grow AUM and margins simultaneously.

Highlights continued inflows across the US and Europe, suggesting demand resilience in both regions.

Acquisition-driven AUM growth and European product launches reinforce cross-border distribution as a growth lever.

Counterpoint

Gross margin declined QoQ (82.9% vs prior quarter) and expenses are rising for anticipated fund launches, which could pressure future profitability if inflows slow.

Key entities

  • WisdomTree, Inc.

    Reports Q2 2026 results, record AUM, net inflows, margin expansion, convertible note retirement, and a quarterly dividend.

  • Atlantic House Holdings Limited

    London-based systematic manager acquired in May 2026, contributing to AUM growth and revenue yield.

  • Ceres Partners, LLC

    Referenced as contributing to year-to-date operating margin expansion.

Related articles

$WTMed

WisdomTree reports $13.5B net inflows, 7th record AUM quarter

WisdomTree (NYSE: WT) reported $168.9B in assets under management (AUM) for Q3, marking its seventh record quarter. The firm saw $1.2B in net inflows for September and $13.5B year-to-date, with UCITS products contributing $700M in September. Fixed income led inflows, while emerging market equity saw outflows. WisdomTree's tokenized AUM grew 65% year-to-date to $1.3B. The company's blended average fee rate was 36 basis points.

$WTMed

WisdomTree (WT) Stock Is Up, What You Need To Know

WisdomTree (WT) stock rose 2.9% after Goldman Sachs increased its price target to $21.30, citing improved earnings and industry outlook. Shares later settled at $24.40, up 1.5% from the previous close. WT has seen volatility, with 11 moves over 5% in the past year. The stock is up 95% YTD, near its 52-week high of $25.04.

$WTMed

WT Maintained by Craig-Hallum -- Price Target Raised to $29.00

Craig-Hallum raised its price target for WisdomTree (WT) to $29.00 from $24.00, maintaining a 'Buy' rating. The stock is currently priced at $24.73, which GuruFocus deems 40.1% overvalued. WT has a GF Score™ of 82/100, showing strong performance but concerns over valuation. Insiders have sold $736,800 in shares recently, with no purchases.

$WTMed

WT Maintained by Goldman Sachs -- Price Target Raised to $21.30

Goldman Sachs maintained a Neutral rating on WisdomTree (WT) but raised its price target to $21.30 from $18.30. GuruFocus values WT at $17.65, suggesting a 41% overvaluation. The company has a GF Score of 82/100, with strong profitability and growth but low valuation metrics. Insiders have sold $736,800 worth of shares in the last three months.

$WTMed

Should You Buy WisdomTree (WT) Stock After Its Latest Crypto Move?

WisdomTree (WT) reported record AUM of $162.9B in Q2 2026, up 30% YoY, with revenue at $177.2M and 40.5% operating margin. The company partnered with MoonPay to integrate its tokenized fund WTGXX, accessing 35M accounts. Despite GAAP losses from debt repurchases, management highlights long-term growth potential in digital assets. WT trades at a forward P/E of 17.30.

$WTMed

WisdomTree (NYSE:WT) Delivers Strong Q2 CY2026 Numbers

Asset management firm WisdomTree (NYSE: WT) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 57.3% year on year to $177.2 million. Its non-GAAP profit of $0.31 per share was 17.3% above analysts’ consensus estimates. Is now the time to buy WisdomTree? Find out by accessing our full research report, it’s free. "The second quarter demonstrated the quality of WisdomTree's growth.